The Association for Research in Vision and Opthalmology (ARVO) 2018
APL-2, A Complement C3 Inhibitor, Slows The Growth Of Geographic Atrophy Secondary To AMD: 18-Month Results Of A Phase 2 Trial (FILLY)
Back to Conference Resources
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.